These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8612435)

  • 1. Phospholipid and glutamic acid decarboxylase autoantibodies in diabetic neuropathy.
    Vinik AI; Leichter SB; Pittenger GL; Stansberry KB; Holland MT; Powers AC; Suwanwalaikorn S
    Diabetes Care; 1995 Sep; 18(9):1225-32. PubMed ID: 8612435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy.
    Zanone MM; Petersen JS; Peakman M; Mathias CJ; Watkins PJ; Dyrberg T; Vergani D
    Diabetes; 1994 Sep; 43(9):1146-51. PubMed ID: 8070615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.
    Roll U; Nuber A; Schröder A; Gerlach E; Janka HU; Ziegler AG
    Diabetes Care; 1995 Feb; 18(2):210-5. PubMed ID: 7729299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy.
    Tuomi T; Zimmet PZ; Rowley MJ; Serjeantson SW; Mackay IR
    Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590
    [No Abstract]   [Full Text] [Related]  

  • 5. No relationship between antibodies to GAD and microangiopathic complications in young Chinese diabetic patients.
    Ko GT; Cockram CS; Critchley JA; Lau MS; Chan JC
    Diabetes Care; 2000 Jul; 23(7):1045-6. PubMed ID: 10895881
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoantibodies to sympathetic ganglia, GAD, or tyrosine phosphatase in long-term IDDM with and without ECG-based cardiac autonomic neuropathy.
    Muhr D; Mollenhauer U; Ziegler AG; Haslbeck M; Standl E; Schnell O
    Diabetes Care; 1997 Jun; 20(6):1009-12. PubMed ID: 9167116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus.
    Zanone MM; Peakman M; Purewal T; Watkins PJ; Vergani D
    Diabetologia; 1993 Jun; 36(6):564-9. PubMed ID: 8335180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies against autonomic nervous tissues in type 2 diabetes mellitus: no association with cardiac autonomic dysfunction.
    Schnell O; Schwarz A; Muhr-Becker D; Standl E
    Exp Clin Endocrinol Diabetes; 2000; 108(3):181-6. PubMed ID: 10926313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ganglioside autoantibodies in type 1 diabetes.
    Lucchetta M; Rudilosso S; Costa S; Bruttomesso D; Ruggero S; Toffanin E; Faggian D; Plebani M; Battistin L; Alaedini A; Briani C
    Muscle Nerve; 2010 Jan; 41(1):50-3. PubMed ID: 19768773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of autoantibodies against reactive oxygen species modified glutamic acid decarboxylase-65 in type 1 diabetes associated complications.
    Khan MW; Banga K; Mashal SN; Khan WA
    BMC Immunol; 2011 Mar; 12():19. PubMed ID: 21385406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum autoantibodies against sulfatide and phospholipid in NIDDM patients with diabetic neuropathy.
    Shigeta H; Yamaguchi M; Nakano K; Obayashi H; Takemura R; Fukui M; Fujii M; Yoshimori K; Hasegawa G; Nakamura N; Kitagawa Y; Kondo M
    Diabetes Care; 1997 Dec; 20(12):1896-9. PubMed ID: 9405914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
    Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
    Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy.
    Zerbini G; Bazzigaluppi E; Mangili R; Bosi E; Bonifacio E
    Diabetologia; 1997 Apr; 40(4):485. PubMed ID: 9112029
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and progression of diabetic retinopathy in patients with Type 1 diabetes who are positive for GAD autoantibody.
    Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Noma H; Amano S; Araie M; Iwamoto Y; Hori S
    Diabet Med; 2004 Jun; 21(6):559-62. PubMed ID: 15154939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase.
    Hayakawa N; Premawardhana LD; Powell M; Masuda M; Arnold C; Sanders J; Evans M; Chen S; Jaume JC; Baekkeskov S; Smith BR; Furmaniak J
    Autoimmunity; 2002 Aug; 35(5):343-55. PubMed ID: 12515289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy.
    Mimura T; Funatsu H; Uchigata Y; Kitano S; Shimizu E; Amano S; Yamagami S; Noma H; Araie M; Hori S
    Ophthalmology; 2005 Nov; 112(11):1904-9. PubMed ID: 16157380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to L-periaxin in sera of patients with peripheral neuropathy produce experimental sensory nerve conduction deficits.
    Lawlor MW; Richards MP; De Vries GH; Fisher MA; Stubbs EB
    J Neurochem; 2002 Nov; 83(3):592-600. PubMed ID: 12390521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
    Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.